DeltaDOT appointed Richard Lingard as vice president of Sales. He was previously director of Strategic Alliances for Invitrogen. SRU Biosystems exclusively licensed Novartis’s Evanescent Resonance technology for drug discovery applications. The technology enables enhanced sensitivity to fluorescence-based assays. In April, Caliper Life Sciences named John DelliSanti executive vice president and chief commercial officer. He previously […]
Northbrook, IL 6/12/07—IDEX has acquired Quadro Engineering, a provider of particle control solutions for the pharmaceutical and biopharmaceutical industries for $31 million in cash. Quadro Engineering specializes in products for fine milling, emulsification and special handling of liquid and solid particulates for lab, pilot phase and production scale processing. Based in Ontario, Canada, the company […]
According to Chemical & Engineering News’ yearly survey of the top 50 US companies in the chemical industry, 2006 was not an eventful year. Combined sales of the surveyed companies reached $299.3 billion, a 6.3% increase over 2005. This sales growth is down from last year’s 10.9% increase, and is a far cry from the […]
Consulting firm Taratec introduced Intelligent Solutions-LAB, a family of services designed to improve laboratory performance and productivity. It includes Operations Intelligence-LAB, Workflow Intelligence-LAB and Technology Intelligence-LAB. Thermo Scientific Asset Management Services appointed a specialized European team and launched a tailored service solutions with a focus on the UK, Germany, France, Spain, Italy, the Netherlands and […]
New York, NY 5/30/07—Enzo Life Sciences, a subsidiary of Enzo Biochem, has signed an agreement to acquire Axxora Life Sciences for approximately $16.3 million in cash. Axxora, based in San Diego, California, manufactures and markets life science reagents. Two of Axxora’s divisions, ALEXIS Biochemicals and Apotech, are based in Switzerland, and manufacture a variety of […]
In April, President Vladimir Putin announced the Presidential Nanotechnology Initiative. At least RUB 28 billion ($1.1 billion) in government funding will be allocated for the initiative through 2010; some funds will go to the purchasing new laboratory equipment. According to the Russian government, RUB 150 billion ($5.8 billion) has already been invested in nanotechnology. Putin […]
Applied Biosystems released the BigDye Xterminator Purification Kit to shorten the time and work required to perform purification prior to Sanger sequencing. Luminex launched the MagPlex microspheres, enabling automated xMAP-based assays. PerkinElmer introduced the Immuno-catch Kit, featuring immuno-capture technology, for MS detection. Agilent launched the Small RNA Kit for its 2100 Bioanalyzer microfluidics system. Molecular […]
According to a report by Marks & Clerk, a law firm specializing in intellectual property, advances in biotechnology are being driven by universities and public research institutes. The most biotech patent families—“groups of patents associated with a single invention”—filed in the period 2002–2006 was 1,022, by the Japan Science and Technology Agency, followed by the […]
London, UK 5/30/07—The UK’s Competition Commission (CC) has published its final decision that Thermo Fisher Scientific’s purchase of GV Instruments (see IBO 7/31/06) “would lead to higher prices, or other adverse effects, for customers of some Isotope Ratio Mass Spectrometry (IRMS) instruments” (see IBO 3/15/07). The CC’s findings specify that the acquisition of GV Instruments […]
Cambridge, MA 5/24/07; Washington, DC 5/24/07—Helicos Biosciences completed the initial public offering of its common stock on the NASDAQ Global Market on May 24 with a pricing of 5.4 million shares at $9 per share (see IBO 2/28/07). The company had initially announced the offering at $13–$15 per share on May 7 and lowered it […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
